Lycopene inhibits neointimal hyperplasia through regulating lipid metabolism and suppressing oxidative stress

Min Mao1, Han Lei1, Qing Liu2

  • 1Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.

Insights

Lycopene effectively inhibits neointimal hyperplasia in restenosis models by regulating lipid metabolism and reducing oxidative stress. This natural compound shows promise as a therapeutic agent for preventing arterial narrowing.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Nutritional Science

Background:

  • Neointimal hyperplasia is a key pathological process in arterial restenosis, often leading to cardiovascular events.
  • Oxidative stress and dysregulated lipid metabolism are significant contributors to the development of neointimal hyperplasia.
  • Identifying novel therapeutic strategies to inhibit neointimal hyperplasia is crucial for cardiovascular disease management.

Purpose of the Study:

  • To elucidate the mechanisms by which lycopene inhibits neointimal hyperplasia in experimental restenosis models.
  • To evaluate the effects of lycopene on lipid metabolism and oxidative stress markers in the context of arterial restenosis.
  • To assess the potential of lycopene as a therapeutic agent for preventing or treating neointimal hyperplasia.

Main Methods:

  • A rabbit carotid artery restenosis model was established, with animals randomized into sham, model, apocynin-treated, and lycopene-treated groups.
  • Immunohistochemistry and transmission electron microscopy (TEM) were employed to analyze carotid plaque morphology, lipid accumulation, and foam cell formation.
  • Quantitative polymerase chain reaction (qPCR) and western blot analysis were used to measure the expression of genes and proteins involved in cell proliferation, oxidative stress, and lipid metabolism.

Main Results:

  • Lycopene treatment significantly reduced intima/media ratios, lipid accumulation, and foam cell formation in carotid plaques.
  • Lycopene modulated blood lipid profiles and suppressed oxidative stress markers in the restenosis model.
  • Gene and protein expression analysis revealed that lycopene decreased the levels of proliferation-associated proteins and those involved in lipid synthesis and transport.

Conclusions:

  • Lycopene demonstrates significant inhibitory effects on neointimal hyperplasia in a rabbit restenosis model.
  • The therapeutic potential of lycopene stems from its ability to regulate lipid metabolism and attenuate oxidative stress.
  • Lycopene represents a promising natural compound for the development of novel treatments against neointimal hyperplasia and related cardiovascular conditions.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
13.6K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.4K